Surrey, United Kingdom

Allan John Miller


Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 143(Granted Patents)


Location History:

  • Surrey, GB (1998 - 1999)
  • Thames Ditton, GB (2000)

Company Filing History:


Years Active: 1998-2000

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Allan John Miller

Introduction: Allan John Miller is an accomplished inventor based in Surrey, Great Britain, known for his contributions to the field of pharmaceuticals. With a strong focus on developing innovative medicaments, he holds a total of four patents that demonstrate his expertise and dedication to addressing medical challenges.

Latest Patents: Among his latest patents, Allan has made significant strides with his work on the use of theophylline for the manufacture of a medicament, targeting various health conditions. Additionally, he developed a synergistic composition of codeine and ibuprofen aimed at treating arthritis. This invention combines a non-steroidal anti-inflammatory drug with an opioid analgesic for enhanced efficacy in arthritis treatment.

Career Highlights: Allan John Miller has made substantial contributions through his affiliation with Euro-Celtique S.A., a company specializing in pharmaceuticals. His innovative work not only showcases his inventiveness but also highlights the importance of research and development in the medical field.

Collaborations: Throughout his career, Allan has collaborated with notable coworkers such as Ronald Brown Miller and Stephen Gordon Douglas. These partnerships have enabled him to share expertise and drive collective innovation in the pharmaceutical sector.

Conclusion: Allan John Miller's dedication to innovation in medicine is evident through his patents and collaborations. As he continues to refine his work on impactful medicaments, his contributions are poised to make significant advancements in the treatment of various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…